Journal of the Neurological Sciences, ISSN 0022-510X, 2011, Volume 312, Issue 1, pp. 196 - 196
Journal Article
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 10/2018, Volume 46, Issue 3, pp. 427 - 430
To rationally plan acute services, the proportion of ischemic strokes that may be eligible for revascularization treatments should be estimated. We aimed to...
Thrombectomy | Eligibility | Medicine & Public Health | Hematology | Ischemic stroke | Cardiology | Thrombolysis | Guidelines | PERIPHERAL VASCULAR DISEASE | ENDOVASCULAR THROMBECTOMY | HEMATOLOGY | Stroke (Disease) | Medicine, Experimental | Medical research | Models | Ischemia | Analysis | Cardiovascular system | Stroke | Intravenous administration | Data processing | Patients
Thrombectomy | Eligibility | Medicine & Public Health | Hematology | Ischemic stroke | Cardiology | Thrombolysis | Guidelines | PERIPHERAL VASCULAR DISEASE | ENDOVASCULAR THROMBECTOMY | HEMATOLOGY | Stroke (Disease) | Medicine, Experimental | Medical research | Models | Ischemia | Analysis | Cardiovascular system | Stroke | Intravenous administration | Data processing | Patients
Journal Article
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 4/2017, Volume 43, Issue 3, pp. 302 - 305
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11239-017-1475-3
Medicine & Public Health | Hematology | Cardiology | PERIPHERAL VASCULAR DISEASE | THERAPY | HEMATOLOGY | ASSOCIATION | ACUTE ISCHEMIC-STROKE | Care and treatment | Usage | Anticoagulants (Medicine) | Atrial fibrillation
Medicine & Public Health | Hematology | Cardiology | PERIPHERAL VASCULAR DISEASE | THERAPY | HEMATOLOGY | ASSOCIATION | ACUTE ISCHEMIC-STROKE | Care and treatment | Usage | Anticoagulants (Medicine) | Atrial fibrillation
Journal Article
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 2/2017, Volume 43, Issue 2, pp. 248 - 251
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11239-016-1430-8
Medicine & Public Health | Hematology | Cardiology | PERIPHERAL VASCULAR DISEASE | NONVALVULAR ATRIAL-FIBRILLATION | HEMATOLOGY | ASSOCIATION | Stroke - pathology | Acute Disease | Administration, Oral | Brain Ischemia - drug therapy | Humans | Anticoagulants - therapeutic use | Stroke - drug therapy | Stroke (Disease) | Ischemia | Anticoagulants (Medicine)
Medicine & Public Health | Hematology | Cardiology | PERIPHERAL VASCULAR DISEASE | NONVALVULAR ATRIAL-FIBRILLATION | HEMATOLOGY | ASSOCIATION | Stroke - pathology | Acute Disease | Administration, Oral | Brain Ischemia - drug therapy | Humans | Anticoagulants - therapeutic use | Stroke - drug therapy | Stroke (Disease) | Ischemia | Anticoagulants (Medicine)
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 113, Issue 2, pp. 440 - 444
Letters to the Editor | DABIGATRAN ANTICOAGULATION | MANAGEMENT | TISSUE-PLASMINOGEN ACTIVATOR | ACUTE ISCHEMIC-STROKE | PERIPHERAL VASCULAR DISEASE | SAFE | HEMATOLOGY | Dabigatran - adverse effects | Pyrazoles - therapeutic use | Humans | Middle Aged | Male | Tissue Plasminogen Activator - therapeutic use | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Dabigatran - therapeutic use | Tissue Plasminogen Activator - adverse effects | Contraindications | Kidney Function Tests | Drug Interactions | Rivaroxaban - adverse effects | Thrombolytic Therapy - methods | Aged, 80 and over | Female | Retrospective Studies | Rivaroxaban - therapeutic use | Pyrazoles - adverse effects | Cerebral Hemorrhage - chemically induced | Drug Administration Schedule | Administration, Oral | Antithrombins - therapeutic use | Endovascular Procedures | Anticoagulants - therapeutic use | Tissue Plasminogen Activator - administration & dosage | Stroke - drug therapy | Anticoagulants - adverse effects | Factor Xa Inhibitors - therapeutic use | Thrombectomy | Cerebral Hemorrhage - epidemiology | Antithrombins - adverse effects | Factor Xa Inhibitors - adverse effects | Aged | Pyridones - therapeutic use | Infusions, Intravenous | Pyridones - adverse effects | Practice Guidelines as Topic
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2017, Volume 244, pp. 282 - 284
Abstract Background To date, very little is known about the effects of direct oral anticoagulants (DOA) use in patients with cervical artery dissection (CAD)...
Cardiovascular | Cervical artery dissection | Direct oral anticoagulants | Non-vitamin K anticoagulants | New oral anticoagulants | Cerebral venous thrombosis | CARDIAC & CARDIOVASCULAR SYSTEMS | INHIBITOR | Aneurysm, Dissecting - diagnosis | Venous Thrombosis - diagnosis | Anticoagulants - administration & dosage | Venous Thrombosis - drug therapy | Administration, Oral | Humans | Middle Aged | Stroke - diagnosis | Male | Treatment Outcome | Intracranial Aneurysm - diagnosis | Stroke - drug therapy | Aneurysm, Dissecting - drug therapy | Adult | Female | Intracranial Thrombosis - diagnosis | Intracranial Thrombosis - drug therapy | Retrospective Studies | Intracranial Aneurysm - drug therapy | Stroke (Disease) | Care and treatment | Thrombophlebitis | Anticoagulants (Medicine) | Analysis | Surgery
Cardiovascular | Cervical artery dissection | Direct oral anticoagulants | Non-vitamin K anticoagulants | New oral anticoagulants | Cerebral venous thrombosis | CARDIAC & CARDIOVASCULAR SYSTEMS | INHIBITOR | Aneurysm, Dissecting - diagnosis | Venous Thrombosis - diagnosis | Anticoagulants - administration & dosage | Venous Thrombosis - drug therapy | Administration, Oral | Humans | Middle Aged | Stroke - diagnosis | Male | Treatment Outcome | Intracranial Aneurysm - diagnosis | Stroke - drug therapy | Aneurysm, Dissecting - drug therapy | Adult | Female | Intracranial Thrombosis - diagnosis | Intracranial Thrombosis - drug therapy | Retrospective Studies | Intracranial Aneurysm - drug therapy | Stroke (Disease) | Care and treatment | Thrombophlebitis | Anticoagulants (Medicine) | Analysis | Surgery
Journal Article
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 10/2016, Volume 42, Issue 3, pp. 393 - 398
Direct oral anticoagulants (DOACs) are superior to warfarin in reduction of the intracranial bleeding risk. The aim of the present study was to assess whether...
Stroke | Medicine & Public Health | Hematology | New oral anticoagulants | Non-valvular atrial fibrillation | Direct oral anticoagulants | Cardiology | Non-VKA oral anticoagulants | Cardioembolic | CARDIAC & CARDIOVASCULAR SYSTEMS | PROTECTION | RIVAROXABAN | HEMORRHAGIC TRANSFORMATION | ACUTE ISCHEMIC-STROKE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Embolism - complications | Atrial Fibrillation - drug therapy | Humans | Atrial Fibrillation - complications | Intracranial Hemorrhages - etiology | Stroke - complications | Anticoagulants - therapeutic use | Male | Secondary Prevention | Stroke - drug therapy | Anticoagulants - adverse effects | Time Factors | Female | Aged | Retrospective Studies | Intracranial Hemorrhages - prevention & control | Stroke (Disease) | CT imaging | Warfarin | Stroke patients | Analysis | Atrial fibrillation
Stroke | Medicine & Public Health | Hematology | New oral anticoagulants | Non-valvular atrial fibrillation | Direct oral anticoagulants | Cardiology | Non-VKA oral anticoagulants | Cardioembolic | CARDIAC & CARDIOVASCULAR SYSTEMS | PROTECTION | RIVAROXABAN | HEMORRHAGIC TRANSFORMATION | ACUTE ISCHEMIC-STROKE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Embolism - complications | Atrial Fibrillation - drug therapy | Humans | Atrial Fibrillation - complications | Intracranial Hemorrhages - etiology | Stroke - complications | Anticoagulants - therapeutic use | Male | Secondary Prevention | Stroke - drug therapy | Anticoagulants - adverse effects | Time Factors | Female | Aged | Retrospective Studies | Intracranial Hemorrhages - prevention & control | Stroke (Disease) | CT imaging | Warfarin | Stroke patients | Analysis | Atrial fibrillation
Journal Article
Neurology, ISSN 0028-3878, 03/2016, Volume 86, Issue 9, pp. 880 - 881
Journal Article
DIABETES, ISSN 0012-1797, 09/2019, Volume 68, Issue 9, pp. 1861 - 1869
Available data from observational studies on the association of admission hyperglycemia (aHG) with outcomes of patients with acute ischemic stroke (AIS)...
OXIDATIVE STRESS | ACTIVATION | MANAGEMENT | ALTEPLASE | SAFE IMPLEMENTATION | GLUCOSE | PREDICTORS | ENDOCRINOLOGY & METABOLISM | SYMPTOMATIC INTRACRANIAL HEMORRHAGE | ADMISSION HYPERGLYCEMIA | POSTSTROKE HYPERGLYCEMIA | Stroke (Disease) | Diabetics | Hyperglycemia | Care and treatment | Usage | Patient outcomes | Health aspects | Risk factors | Thrombolytic therapy
OXIDATIVE STRESS | ACTIVATION | MANAGEMENT | ALTEPLASE | SAFE IMPLEMENTATION | GLUCOSE | PREDICTORS | ENDOCRINOLOGY & METABOLISM | SYMPTOMATIC INTRACRANIAL HEMORRHAGE | ADMISSION HYPERGLYCEMIA | POSTSTROKE HYPERGLYCEMIA | Stroke (Disease) | Diabetics | Hyperglycemia | Care and treatment | Usage | Patient outcomes | Health aspects | Risk factors | Thrombolytic therapy
Journal Article
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 11/2016, Volume 42, Issue 4, pp. 585 - 585
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11239-016-1392-x
Medicine & Public Health | Hematology | Cardiology | HEMATOLOGY | PERIPHERAL VASCULAR DISEASE | Humans | Thrombolytic Therapy | Observational Studies as Topic | Female | Male | Stroke - therapy | Randomized Controlled Trials as Topic
Medicine & Public Health | Hematology | Cardiology | HEMATOLOGY | PERIPHERAL VASCULAR DISEASE | Humans | Thrombolytic Therapy | Observational Studies as Topic | Female | Male | Stroke - therapy | Randomized Controlled Trials as Topic
Journal Article
Neurology, ISSN 0028-3878, 03/2016, Volume 86, Issue 9, pp. 880 - 881
Journal Article
Stroke, ISSN 0039-2499, 06/2013, Volume 44, Issue 6
Journal Article
Stroke, ISSN 0039-2499, 12/2019
Journal Article
Journal of Stroke and Cerebrovascular Diseases, ISSN 1052-3057, 2017, Volume 26, Issue 8, pp. e150 - e152
Data from randomized clinical trials and current guidelines suggest that patients with anterior circulation occlusion with contraindications to intravenous...
Neurology | Cardiovascular | mechanical thrombectomy | large vessel occlusion | Intracerebral hemorrhage | ischemic stroke | GUIDELINES | PERIPHERAL VASCULAR DISEASE | NEUROSCIENCES | Infarction, Middle Cerebral Artery - physiopathology | Humans | Middle Aged | Treatment Outcome | Cerebrovascular Circulation | Infarction, Middle Cerebral Artery - therapy | Cerebral Angiography - methods | Cerebral Hemorrhage - physiopathology | Cerebral Hemorrhage - diagnostic imaging | Computed Tomography Angiography | Infarction, Middle Cerebral Artery - complications | Thrombectomy - methods | Female | Cerebral Hemorrhage - complications | Infarction, Middle Cerebral Artery - diagnostic imaging | Stroke (Disease) | Ischemia | Neurosciences
Neurology | Cardiovascular | mechanical thrombectomy | large vessel occlusion | Intracerebral hemorrhage | ischemic stroke | GUIDELINES | PERIPHERAL VASCULAR DISEASE | NEUROSCIENCES | Infarction, Middle Cerebral Artery - physiopathology | Humans | Middle Aged | Treatment Outcome | Cerebrovascular Circulation | Infarction, Middle Cerebral Artery - therapy | Cerebral Angiography - methods | Cerebral Hemorrhage - physiopathology | Cerebral Hemorrhage - diagnostic imaging | Computed Tomography Angiography | Infarction, Middle Cerebral Artery - complications | Thrombectomy - methods | Female | Cerebral Hemorrhage - complications | Infarction, Middle Cerebral Artery - diagnostic imaging | Stroke (Disease) | Ischemia | Neurosciences
Journal Article
15.
Full Text
Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 5/2017, Volume 43, Issue 4, pp. 528 - 529
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11239-017-1485-1
Medicine & Public Health | Hematology | Cardiology | HEMATOLOGY | PERIPHERAL VASCULAR DISEASE
Medicine & Public Health | Hematology | Cardiology | HEMATOLOGY | PERIPHERAL VASCULAR DISEASE
Journal Article
Stroke, ISSN 0039-2499, 02/2018, Volume 49, Issue 2, pp. 397 - 404
BACKGROUND AND PURPOSE—Symptomatic intracerebral hemorrhage (sICH) is a rare but the most feared complication of intravenous thrombolysis for ischemic stroke....
Clopidogrel | Stroke | Calibration | Hemorrhage | Nomograms | clopidogrel | nomograms | RISK | EXTERNAL VALIDATION | SEDAN SCORE | stroke | INTRACRANIAL HEMORRHAGE | CLINICAL NEUROLOGY | THERAPY | PLASMINOGEN-ACTIVATOR | WARFARIN | ACUTE ISCHEMIC-STROKE | PROSTATE-CANCER | PERIPHERAL VASCULAR DISEASE | RETROSPECTIVE ANALYSIS | calibration | hemorrhage | Stroke (Disease) | Usage | Diagnosis | Nomography (Mathematics) | Innovations | Computational biology
Clopidogrel | Stroke | Calibration | Hemorrhage | Nomograms | clopidogrel | nomograms | RISK | EXTERNAL VALIDATION | SEDAN SCORE | stroke | INTRACRANIAL HEMORRHAGE | CLINICAL NEUROLOGY | THERAPY | PLASMINOGEN-ACTIVATOR | WARFARIN | ACUTE ISCHEMIC-STROKE | PROSTATE-CANCER | PERIPHERAL VASCULAR DISEASE | RETROSPECTIVE ANALYSIS | calibration | hemorrhage | Stroke (Disease) | Usage | Diagnosis | Nomography (Mathematics) | Innovations | Computational biology
Journal Article
Annals of Neurology, ISSN 0364-5134, 03/2018, Volume 83, Issue 3, pp. 451 - 459
Objective Information about rivaroxaban plasma level (RivLev) may guide treatment decisions in patients with acute ischemic stroke (AIS) and intracerebral...
INTRAVENOUS THROMBOLYSIS | FACTOR XA | MANAGEMENT | ORAL ANTICOAGULANTS | GUIDELINES | IV THROMBOLYSIS | COMPLICATIONS | INHIBITORS | HEALTH-CARE PROFESSIONALS | ASSOCIATION | NEUROSCIENCES | CLINICAL NEUROLOGY | Brain Ischemia - epidemiology | Cerebral Hemorrhage - drug therapy | Rivaroxaban - blood | Follow-Up Studies | Humans | Male | Stroke - drug therapy | Cerebral Hemorrhage - blood | Stroke - blood | Factor Xa Inhibitors - therapeutic use | Brain Ischemia - blood | Cerebral Hemorrhage - epidemiology | Factor Xa Inhibitors - blood | Brain Ischemia - drug therapy | Aged, 80 and over | Female | Registries | Stroke - epidemiology | Aged | Rivaroxaban - therapeutic use | Cohort Studies | Anticoagulants | Stroke | Renal function | Thresholds | Decisions | Regression analysis | Hemorrhage | Patients | Thrombolysis | Sensitivity | Regression models | Ischemia | Correlation analysis | Plasma levels
INTRAVENOUS THROMBOLYSIS | FACTOR XA | MANAGEMENT | ORAL ANTICOAGULANTS | GUIDELINES | IV THROMBOLYSIS | COMPLICATIONS | INHIBITORS | HEALTH-CARE PROFESSIONALS | ASSOCIATION | NEUROSCIENCES | CLINICAL NEUROLOGY | Brain Ischemia - epidemiology | Cerebral Hemorrhage - drug therapy | Rivaroxaban - blood | Follow-Up Studies | Humans | Male | Stroke - drug therapy | Cerebral Hemorrhage - blood | Stroke - blood | Factor Xa Inhibitors - therapeutic use | Brain Ischemia - blood | Cerebral Hemorrhage - epidemiology | Factor Xa Inhibitors - blood | Brain Ischemia - drug therapy | Aged, 80 and over | Female | Registries | Stroke - epidemiology | Aged | Rivaroxaban - therapeutic use | Cohort Studies | Anticoagulants | Stroke | Renal function | Thresholds | Decisions | Regression analysis | Hemorrhage | Patients | Thrombolysis | Sensitivity | Regression models | Ischemia | Correlation analysis | Plasma levels
Journal Article
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 4/2017, Volume 43, Issue 3, pp. 394 - 400
The availability of prediction tools for risk stratification after acute stroke is seen as a valuable perspective for tailored clinical management. This...
Stroke | Cerebral ischemia | Medicine & Public Health | Hematology | Outcome | Nomogram | Prediction | Cardiology | Red blood cell distribution width | SURVIVAL | MATTER | CARDIAC & CARDIOVASCULAR SYSTEMS | CELL DISTRIBUTION WIDTH | PROGNOSIS | SCALE SCORE | RECOVERY | ATLANTIS | POOLED ANALYSIS | PERIPHERAL VASCULAR DISEASE | OUTCOMES | HEMATOLOGY | SEVERITY | Severity of Illness Index | Multivariate Analysis | Predictive Value of Tests | Brain Ischemia | Age Factors | Humans | Middle Aged | Stroke - complications | Male | Thrombolytic Therapy | Nomograms | Aged, 80 and over | Erythrocytes - pathology | Female | Aged | Retrospective Studies | Stroke (Disease) | Usage | Ischemia | Analysis
Stroke | Cerebral ischemia | Medicine & Public Health | Hematology | Outcome | Nomogram | Prediction | Cardiology | Red blood cell distribution width | SURVIVAL | MATTER | CARDIAC & CARDIOVASCULAR SYSTEMS | CELL DISTRIBUTION WIDTH | PROGNOSIS | SCALE SCORE | RECOVERY | ATLANTIS | POOLED ANALYSIS | PERIPHERAL VASCULAR DISEASE | OUTCOMES | HEMATOLOGY | SEVERITY | Severity of Illness Index | Multivariate Analysis | Predictive Value of Tests | Brain Ischemia | Age Factors | Humans | Middle Aged | Stroke - complications | Male | Thrombolytic Therapy | Nomograms | Aged, 80 and over | Erythrocytes - pathology | Female | Aged | Retrospective Studies | Stroke (Disease) | Usage | Ischemia | Analysis
Journal Article
19.
Full Text
Circadian variation in the effect of intravenous thrombolysis after non-lacunar stroke
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 8/2014, Volume 38, Issue 2, pp. 253 - 259
The onset of non-lacunar stroke symptoms has a circadian variation, with a higher risk in the early morning hours and lower risk during the nighttime period,...
Stroke | Alteplase | Medicine & Public Health | Hematology | Outcome | Cardiology | Circadian | Thrombolysis | Fibrinolysis | TISSUE-PLASMINOGEN ACTIVATOR | TIME | TRIAL | ACUTE ISCHEMIC-STROKE | PERIPHERAL VASCULAR DISEASE | EXPERIENCE | HEMATOLOGY | Follow-Up Studies | Humans | Middle Aged | Male | Stroke - drug therapy | Tissue Plasminogen Activator - therapeutic use | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy | Aged, 80 and over | Female | Aged | Retrospective Studies | Circadian Rhythm - drug effects | Stroke (Disease) | Neurosciences | Analysis
Stroke | Alteplase | Medicine & Public Health | Hematology | Outcome | Cardiology | Circadian | Thrombolysis | Fibrinolysis | TISSUE-PLASMINOGEN ACTIVATOR | TIME | TRIAL | ACUTE ISCHEMIC-STROKE | PERIPHERAL VASCULAR DISEASE | EXPERIENCE | HEMATOLOGY | Follow-Up Studies | Humans | Middle Aged | Male | Stroke - drug therapy | Tissue Plasminogen Activator - therapeutic use | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy | Aged, 80 and over | Female | Aged | Retrospective Studies | Circadian Rhythm - drug effects | Stroke (Disease) | Neurosciences | Analysis
Journal Article
International Journal of Stroke, ISSN 1747-4930, 12/2016, Volume 11, Issue 9, pp. NP91 - NP92
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.